A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia
about
Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injuryImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisA20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularizationThe protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genesGenetic analysis of a mouse cross implicates an anti-inflammatory gene in control of atherosclerosis susceptibility.A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation.O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice.The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells.Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathwaysc-Kit modifies the inflammatory status of smooth muscle cellsHepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomesZinc finger protein A20 protects rats against chronic liver allograft dysfunctionInduction of vascular atrophy as a novel approach to treating restenosis. A reviewA20 deficiency leads to angiogenesis of pulmonary artery endothelial cells through stronger NF-κB activation under hypoxiaNovel A20-gene-eluting stent inhibits carotid artery restenosis in a porcine model.A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.Site-specific gene therapy for cardiovascular disease.Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector.Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease.Artificial Zinc-Finger Transcription Factor of A20 Suppresses Restenosis in Sprague Dawley Rats after Carotid Injury via the PPARα Pathway.Overexpression of the nuclear factor kappaB inhibitor A20 is neurotoxic after an excitotoxic injury to the immature rat brain.Bcl10 is an essential regulator for A20 gene expression.
P2860
Q27301022-15F0A46E-8F5F-4610-95E4-CB41BFDD455CQ28084366-1D0BF5E7-68A0-41E5-B4A2-3F9D30FF61DEQ28588739-459FEF47-9AC7-43B0-954C-66BB9DBAF6DCQ28594304-BEC1A934-EBE8-40B2-8BEB-8B2DCC423566Q30274938-D2208B7F-0FD6-4F91-A9D0-9E40612F6AA0Q30826185-8382AB01-AF02-4E03-A9B7-924BAA37837CQ30993051-A3BF29B1-5303-4070-BADA-FC03572473D7Q33266888-3240DED2-E178-424F-B653-24B3C6DA573AQ33419375-80536419-694B-47FB-B550-18A13CD7B653Q33802517-454E9506-66CD-42A8-A197-E589A98F17ACQ33913784-19508E4F-C515-49F4-9400-AD98A32AD2F7Q34127817-FC7AC999-62C4-49A8-9E5A-AECF204E1A02Q34467421-2FFA2C27-197D-4970-ACA0-A4AE62CC7E06Q35555093-3D6F1A3C-047F-47BB-A25C-CC393602355BQ36105534-594A0743-E67C-44A6-8913-4B7B67E1BC90Q36976632-2FC5275A-A499-43BC-95ED-2685DB88EDD8Q37056985-0DC0AFC3-0B7E-40C8-8C16-B917B534D383Q37170542-6C7E4271-26CF-4B9E-817B-0B75DB7F489FQ37576755-CE0D980B-2FA4-47F2-B874-72B594512BC5Q37703070-B09ED84B-A132-4801-9C4B-D1C63F24A68DQ38901143-031AECBE-2881-4F6C-9EBA-4F418C599421Q39659028-A49E1937-E074-4789-B77A-9122AC06FBA5Q41767441-6DDAB441-E552-47B7-9FA0-AD0ED644DDF0Q42519607-6363E807-73D6-4646-88D6-6648F51B7123Q43821259-34DB1B68-D6FD-4FBB-B053-5D6F948BAD13
P2860
A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@ast
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en-gb
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@nl
type
label
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@ast
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en-gb
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@nl
prefLabel
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@ast
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en-gb
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@nl
P2093
P921
P3181
P356
P1433
P1476
A20, a modulator of smooth mus ...... sion of neointimal hyperplasia
@en
P2093
Caroline M Groft
Christiane Ferran
Christina Motley-Dore
Christopher R Longo
Eva Czismadia
Gautam V Shrikhande
Haley E Ramsey
Maria B Arvelo
Mark D Fisher
Salvatore T Scali
P304
P3181
P356
10.1096/FJ.05-4981COM
P407
P577
2006-07-01T00:00:00Z